1. Home
  2. ARVN vs COFS Comparison

ARVN vs COFS Comparison

Compare ARVN & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • COFS
  • Stock Information
  • Founded
  • ARVN 2015
  • COFS 1898
  • Country
  • ARVN United States
  • COFS United States
  • Employees
  • ARVN N/A
  • COFS N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • COFS Major Banks
  • Sector
  • ARVN Health Care
  • COFS Finance
  • Exchange
  • ARVN Nasdaq
  • COFS Nasdaq
  • Market Cap
  • ARVN 456.2M
  • COFS 448.8M
  • IPO Year
  • ARVN 2018
  • COFS N/A
  • Fundamental
  • Price
  • ARVN $7.90
  • COFS $30.58
  • Analyst Decision
  • ARVN Buy
  • COFS Strong Buy
  • Analyst Count
  • ARVN 22
  • COFS 2
  • Target Price
  • ARVN $20.21
  • COFS $39.00
  • AVG Volume (30 Days)
  • ARVN 1.8M
  • COFS 59.3K
  • Earning Date
  • ARVN 10-29-2025
  • COFS 10-22-2025
  • Dividend Yield
  • ARVN N/A
  • COFS 3.66%
  • EPS Growth
  • ARVN N/A
  • COFS N/A
  • EPS
  • ARVN N/A
  • COFS 1.30
  • Revenue
  • ARVN $372,800,000.00
  • COFS $108,378,000.00
  • Revenue This Year
  • ARVN $4.87
  • COFS $77.76
  • Revenue Next Year
  • ARVN N/A
  • COFS $8.17
  • P/E Ratio
  • ARVN N/A
  • COFS $23.61
  • Revenue Growth
  • ARVN 299.57
  • COFS 30.36
  • 52 Week Low
  • ARVN $5.90
  • COFS $24.89
  • 52 Week High
  • ARVN $29.61
  • COFS $38.15
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 60.55
  • COFS 55.91
  • Support Level
  • ARVN $7.62
  • COFS $29.57
  • Resistance Level
  • ARVN $8.22
  • COFS $31.35
  • Average True Range (ATR)
  • ARVN 0.31
  • COFS 0.55
  • MACD
  • ARVN 0.10
  • COFS 0.04
  • Stochastic Oscillator
  • ARVN 76.98
  • COFS 56.74

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

Share on Social Networks: